Literature DB >> 3970811

Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

S Aamdal, O Fodstad, J M Nesland, A Pihl.   

Abstract

Human tumour lines established in athymic nude mice were grafted under the renal capsule of immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10 sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3. Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had also retained its malignant character. Altogether the results support the view that human tumour xenografts grow well under the renal capsule of immunocompetent mice and that the grafts retain important characteristics of the original tumour.

Entities:  

Mesh:

Year:  1985        PMID: 3970811      PMCID: PMC1976949          DOI: 10.1038/bjc.1985.46

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Chemotherapy of human colon cancer xenografts in athymic nude mice.

Authors:  R Osieka; D P Houchens; A Goldin; R K Johnson
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

2.  Enzyme electrophoresis on cellulose acetate gel: zymogram patterns in mgh-mouse and man--Chinese hamster somatic cell hybrids.

Authors:  P Meera Khan
Journal:  Arch Biochem Biophys       Date:  1971-08       Impact factor: 4.013

3.  Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice.

Authors:  O Fodstad; S Olsnes; A Pihl
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

4.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice.

Authors:  L Kopper; G G Steel
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

5.  Chemotherapy of human tumor xenografts in genetically athymic mice.

Authors:  A A Ovejera; D P Houchens; A D Barker
Journal:  Ann Clin Lab Sci       Date:  1978 Jan-Feb       Impact factor: 1.256

6.  Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors.

Authors:  B C Giovanella; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

7.  Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response.

Authors:  S Aamdal; O Fodstad; A Pihl
Journal:  Int J Cancer       Date:  1984-11-15       Impact factor: 7.396

8.  The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma.

Authors:  R D Watson; A G Smith; J G Levy
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

9.  Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.

Authors:  K Nowak; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

10.  Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice.

Authors:  J A Houghton; D M Taylor
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  6 in total

1.  Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

Authors:  Tristan M Nicholson; Kristen S Uchtmann; Conrad D Valdez; Ashleigh B Theberge; Tihomir Miralem; William A Ricke
Journal:  J Vis Exp       Date:  2013-08-28       Impact factor: 1.355

2.  Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-P.

Authors:  G Edel; A Roessner; B Deneke; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

4.  Anti-Cancer Drug Sensitivity Assay with Quantitative Heterogeneity Testing Using Single-Cell Raman Spectroscopy.

Authors:  Yong Zhang; Jingjing Xu; Yuezhou Yu; Wenhao Shang; Anpei Ye
Journal:  Molecules       Date:  2018-11-07       Impact factor: 4.411

5.  Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner.

Authors:  S Hosokawa; T Tagawa; H Niki; Y Hirakawa; K Nohga; K Nagaike
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

6.  Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.

Authors:  Xiaofen Yao; Zhangli Dong; Qiuwan Zhang; Qian Wang; Dongmei Lai
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.